CollPlant Biotechnologies Ltd. (CLGN) released Loss for third quarter of -$3.483 million
The company's bottom line came in at -$3.483 million, or -$0.27 per share. This compares with -$4.326 million, or -$0.38 per share, last year.
Excluding items, CollPlant Biotechnologies Ltd. reported adjusted earnings of -$3.160 million or -$0.25 per share for the period.
The company's revenue for the period rose 1825.0% to $0.077 million from $0.004 million last year.
CollPlant Biotechnologies Ltd. earnings at a glance (GAAP) :
-Earnings: -$3.483 Mln. vs. -$4.326 Mln. last year.-EPS: -$0.27 vs. -$0.38 last year.-Revenue: $0.077 Mln vs. $0.004 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.